Fig. 6From: Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathiesOverview of total, pSer129, 119CTT, and 122CTT aSyn levels in different synucleinopathies and tauopathies as compared to control subjects. Overview of log10-transformed p-values of group comparisons in detergent-soluble (A) and -insoluble (B) fractions after Dunnett’s post-hoc correction. Colors indicate the significance level for each diagnostic group compared to controls. Note the SN of the AD patients was not processed. HIP = hippocampus; PUT = putamen; SN = substantia nigraBack to article page